|
| Product | Alternate Name | Type | Strength | Quantity | Price (USD) | Buy Now | |
 |
Proamatine |
midodrine |
Brand |
5mg |
100TAB |
$132.00 |
|
|
|
 Save. Save. Save. On Proamatine and more!
Express-medicine.com provides customers like you access to popular top-quality pharmaceuticals at truly competitive prices. Saving you up to 80% on hundreds of medications from our Express Medicine pharmacy!
No Surprises - all your medications will come from licensed pharmacies. Your satisfaction is guaranteed. All our brand & generic products are FDA approved.
-
2010-09-01 07:41:00
ProAmatine, a drug used to treat high blood pressure, faces threat in the pharmaceutical market as US FDA plans to withdraw the drug, originally Milodrine HCl. According to the Food and Drug Administration, drugs need to undergo post-approval research to confirm their medical benefit—to find out whe ...
-
2010-08-31 21:27:00
Please bear with me while I talk about midodrine just a little bit more. This whole situation is complicated, right down to how we are supposed to contact the FDA. I've been given different answers regarding how to best contact them. I really don't know which way is the preferred way, so I'm going t ...
-
2010-08-28 11:20:00
There aren’t many medications made for people like me with dysautonomia. Most medicine we use is off label for our condition. However, 14 years ago a medicine came on the market for people just like me! It is called ProAmatine (generic name is midodrine), and it raises blood pressure. Midodrine has ...
-
2010-08-26 15:03:00
I'm sure that most people with POTS or any other type of Dysautonomia have heard about the Food and Drug Administration's ongoing attempt to withdraw approval of ProAmatine/Midodrine, the medication that many of us with Dysautonomia, and also others with different conditions, take help raise our blo ...
-
2010-08-25 13:47:00
ISSUE: FDA proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition, orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done. To date, neither the original manufacturer no ...
-
2010-08-24 10:30:00
The maker of blood pressure medication ProAmatine will remove the drug from the market, after the U.S. Food and Drug Administration (FDA) threatened to recall the drug because of lack of proof concerning the drug’s long-term benefits. The FDA stated that the maker failed to conduct postmarketing cli ...
-
2010-08-20 14:49:00
Considering the billions of dollars spent on U.S. health care, it's easy to focus on big-picture funding decisions and forget the millions of affected patients. (In fact, we're going to do just that.) This week's news was dominated by numbers and statistics -- from percentages of premiums insurers m ...
-
2010-08-20 14:13:00
The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done. Patients who curren ...
-
2010-08-19 17:08:00
News 2 new results for Article Marketing News Chris Perry Named Vice President, Chevrolet Marketing Sacramento Bee Only post comments relevant to the article at hand. If you want to discuss an issue with a specific user, click on his profile name and send him a direct ... See all stories on this top ...
-
2010-08-19 10:11:00
Ohio drug recall attorneys continue to question FDA after discovering ProAmatine drug to be potentially dangerous. Maybe it required another potentially dangerous drug and the possibility of yet another recall in order for the Food and Drug Administration to take action… After being approved in 1996 ...
-
2010-08-19 06:59:00
Shire says it is removing its low-blood pressure drug ProAmatine from the market, as it isn’t profitable enough to justify the additional clinical tests that the FDA is requiring to stay on the market. The company maintains in a statement that it conducted and completed the post-marketing trials tha ...
-
2010-08-18 13:48:00
Drugmaker Shire has decided to withdraw its low blood pressure drug ProAmatine (midodrine hydrochloride) from the market. Read More…
-
2010-08-18 00:51:00
The Food and Drug Administration has proposed to withdraw its approval for the low-blood pressure drug midodrine hydrochloride because post-approval safety testing has not been conducted. Patients currently taking this drug should consult their physicians and should not stop taking the drug until an ...
-
2010-08-17 19:32:00
Well thank you FDA for bringing this to our attention as clinical trials today versus what they were when the drug was created has grown and only 1% of our over all sales are attributed to this drug, so we’ll just throw in the towel here and take the drug off the market. The drug was approved in 199 ...
-
2010-08-17 13:47:00
The agency said it granted fast-track approval of the drug in 1996 with the stipulation that the manufacturer must conduct post-approval studies—but none of the six manufacturers, which include Maple Grove-based Upsher-Smith, have done so. The U.S. Food and Drug Administration (FDA) has proposed wit ...
|